A detailed history of Shelton Capital Management transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Shelton Capital Management holds 2,971 shares of LNTH stock, worth $324,849. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,971
Holding current value
$324,849
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$58.87 - $83.05 $174,902 - $246,741
2,971 New
2,971 $238,000
Q2 2023

Aug 10, 2023

SELL
$82.41 - $99.65 $8,570 - $10,363
-104 Reduced 2.95%
3,416 $286,000
Q1 2023

May 11, 2023

BUY
$47.76 - $82.86 $168,115 - $291,667
3,520 New
3,520 $290,000
Q1 2022

May 12, 2022

SELL
$24.28 - $56.64 $3,617 - $8,439
-149 Reduced 3.38%
4,264 $236,000
Q4 2021

Feb 11, 2022

BUY
$22.54 - $30.44 $99,469 - $134,331
4,413 New
4,413 $127,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.52B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.